Advisory Resource Group’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-545,196
Closed -$10.3M 144
2022
Q2
$10.3M Buy
545,196
+184,890
+51% +$3.77M 3.39% 6
2022
Q1
$7.71M Sell
360,306
-11,228
-3% -$237K 2.4% 9
2021
Q4
$7.83M Buy
+371,534
New +$7.78M 2.61% 10

Other funds holding REVS

Advisory Resource Group's REVS Position: Q3 2022 in Review

Advisory Resource Group sold out of Columbia Research Enhanced Value ETF (REVS) in Q3 2022, closing a stake of 545,196 shares — an estimated $10.3M sold.

Advisory Resource Group first reported a position in REVS in Q4 2021 and held it in 3 quarters. The position peaked at $10.3M in Q2 2022. 9 funds tracked by Wall St. Rank hold REVS as of Q3 2022.

  • Advisory Resource Group reported no remaining Columbia Research Enhanced Value ETF position as of Q3 2022 after selling out during the quarter.
  • Advisory Resource Group sold 545,196 Columbia Research Enhanced Value ETF shares in Q3 2022, an estimated $10.3M.
  • Advisory Resource Group first reported a position in Columbia Research Enhanced Value ETF in Q4 2021 and held it in 3 quarters.
  • Advisory Resource Group's Columbia Research Enhanced Value ETF position peaked at $10.3M in Q2 2022.
  • 9 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q3 2022.

Based on Advisory Resource Group's 13F filing for Q3 2022, filed 11 Oct 2022.